Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease

表观遗传学 免疫学 生物 癸他滨 免疫系统 癌症研究 基因表达 DNA甲基化 遗传学 基因
作者
Haodong Ding,Yuwei Li,Maoxin Fang,Jiaojiao Chen,Liu Li-pin,Zhigang Lu,Jia Hou,Min Luo
出处
期刊:The Journal of Allergy and Clinical Immunology [Elsevier BV]
卷期号:151 (6): 1622-1633.e10 被引量:4
标识
DOI:10.1016/j.jaci.2023.04.003
摘要

Background X-linked MAGT1 deficiency with increased susceptibility to Epstein-Barr virus infection and N-linked glycosylation defect (XMEN) disease is a rare combined immunodeficiency caused by loss-of-function mutations in the magnesium transporter 1 (MAGT1) gene. MAGT1 deficiency impairs magnesium transport and the N-linked glycosylation of a panel of proteins, which subsequently abolishes the expression of key immune receptors such as natural killer group 2, member D (aka NKG2D). These effects induce immune system abnormalities, chronic Epstein-Barr virus infection, and neoplasia. Recent research shows that MAGT1 and tumor candidate suppressor 3 (TUSC3) share high sequence and functional similarity. Objective We sought to investigate the feasibility of activating TUSC3 expression to provide a potential therapeutic strategy for XMEN disease. Methods The expression profiles of MAGT1 and TUSC3 were analyzed using multiple databases, real-time quantitative PCR, and Western blot. The effects of decitabine and panobinostat on the regulation of TUSC3 expression were explored in both MAGT1 knockout (KO)/patient-derived lymphocytes and MAGT1 KO hepatocytes. Results Although TUSC3 is widely expressed, it is undetectable specifically in the immune system and liver, consistent with the main diseased tissues in patients with XMEN disease. CRISPR/Cas9-mediated KO of MAGT1 in the NKL cell line successfully mimicked the phenotypes of XMEN patient–derived lymphocytes, and exogenous expression of TUSC3 rescued the deficiencies in KO NKL cells. Using this in vitro model, we identified 2 epigenetic drugs, decitabine and panobinostat, by screening. Combination treatment using these 2 drugs significantly upregulated TUSC3 expression and rescued the immune and liver abnormalities. Conclusions Epigenetic activation of TUSC3 expression constitutes an effective therapeutic strategy for XMEN disease. X-linked MAGT1 deficiency with increased susceptibility to Epstein-Barr virus infection and N-linked glycosylation defect (XMEN) disease is a rare combined immunodeficiency caused by loss-of-function mutations in the magnesium transporter 1 (MAGT1) gene. MAGT1 deficiency impairs magnesium transport and the N-linked glycosylation of a panel of proteins, which subsequently abolishes the expression of key immune receptors such as natural killer group 2, member D (aka NKG2D). These effects induce immune system abnormalities, chronic Epstein-Barr virus infection, and neoplasia. Recent research shows that MAGT1 and tumor candidate suppressor 3 (TUSC3) share high sequence and functional similarity. We sought to investigate the feasibility of activating TUSC3 expression to provide a potential therapeutic strategy for XMEN disease. The expression profiles of MAGT1 and TUSC3 were analyzed using multiple databases, real-time quantitative PCR, and Western blot. The effects of decitabine and panobinostat on the regulation of TUSC3 expression were explored in both MAGT1 knockout (KO)/patient-derived lymphocytes and MAGT1 KO hepatocytes. Although TUSC3 is widely expressed, it is undetectable specifically in the immune system and liver, consistent with the main diseased tissues in patients with XMEN disease. CRISPR/Cas9-mediated KO of MAGT1 in the NKL cell line successfully mimicked the phenotypes of XMEN patient–derived lymphocytes, and exogenous expression of TUSC3 rescued the deficiencies in KO NKL cells. Using this in vitro model, we identified 2 epigenetic drugs, decitabine and panobinostat, by screening. Combination treatment using these 2 drugs significantly upregulated TUSC3 expression and rescued the immune and liver abnormalities. Epigenetic activation of TUSC3 expression constitutes an effective therapeutic strategy for XMEN disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
量子星尘发布了新的文献求助10
1秒前
鲸落完成签到,获得积分10
2秒前
xiaoze发布了新的文献求助10
3秒前
打打应助hantuo采纳,获得10
4秒前
孙兆杰完成签到,获得积分10
5秒前
5秒前
5秒前
5秒前
Glow发布了新的文献求助10
5秒前
义气鲂发布了新的文献求助10
6秒前
LSD完成签到,获得积分10
7秒前
鲸落发布了新的文献求助10
7秒前
Pericardium发布了新的文献求助10
7秒前
赘婿应助海棠之秋采纳,获得10
9秒前
10秒前
莫妮卡.宾完成签到,获得积分10
10秒前
认真的白易完成签到,获得积分20
10秒前
11秒前
jeff发布了新的文献求助10
12秒前
12秒前
13秒前
Glow完成签到,获得积分10
13秒前
xuqiansd完成签到,获得积分10
13秒前
文静完成签到,获得积分10
13秒前
14秒前
帕丁顿发布了新的文献求助10
14秒前
汉堡包应助ak采纳,获得10
15秒前
15秒前
dingbeicn完成签到,获得积分10
15秒前
15秒前
希望天下0贩的0应助LFC采纳,获得10
15秒前
15秒前
16秒前
17秒前
Aite发布了新的文献求助10
17秒前
18秒前
18秒前
SYLH应助义气鲂采纳,获得10
19秒前
c0uVi1完成签到,获得积分10
19秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969513
求助须知:如何正确求助?哪些是违规求助? 3514327
关于积分的说明 11173617
捐赠科研通 3249672
什么是DOI,文献DOI怎么找? 1794973
邀请新用户注册赠送积分活动 875537
科研通“疑难数据库(出版商)”最低求助积分说明 804836